Daily Brief Financials: Religare Enterprises, Gravity Acquisition, Leopalace21 Corp, New Iceland Arctic Acquisition and more

• Religare is a financial services company with a crown jewel in Care Health Insurance. However, the stock trades at a material discount due to complex group structuring.
• The poor valuations also stem from corporate governance issues most of which have been put to rest by the management overhaul under new promoters: Burmans of Dabur (DABUR IN)  group
• Company has proposed to spin-off NBFC and broking businesses, leading to indirect listing for India’s second largest standalone health insurer Care Health.

• Gravity Acquisition Corp. is a blank check company incorporated in the Cayman Islands to effect a business combination with one or more entities. Its efforts to identify a target business.
• The management team possesses deep capital markets, M&A execution, and operational experience, including leadership at Tapestry, Mars Acquisition Corp., Joint Fortune Capital, and Tricentis USA Corp.
• Total assets were $250,713,191 as of May 31, 2026 (As Adjusted). The auditor report expresses substantial doubt about the ability to continue as a going concern.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• I tally 37- mostly firm, mostly Asia-Pac – arb transactions currently being discussed and analysed on Smartkarma. Those arbs metrics and upcoming events are detailed below.
• Two new deal was discussed on Smartkarma this week: Tender Offers for Leopalace21 Corp (8848 JP) and Kadoya Sesame Mills (2612 JP).
• Key updates/news also took place on: Cleanaway Waste Management (CWY AU), European Lithium (EUR AU), Gabia Inc (079940 KS), Refine Co Ltd (377450 KS), and FleetPartners Group (FPR AU).

• Icelandic Pension Funds’ Domestic Dominance: Local pension funds manage assets exceeding 180% of GDP (nearly ISK 8.9 trillion), representing the primary competitive threat to NIAA for local renewable and infrastructure assets. Following the summer 2026 amendments to the Icelandic Pensions Act, these funds have gained greater allocation freedom for unlisted assets, compressing local yields and making it extremely difficult for an external SPAC to win on price alone.
• Structural Avoidance of Act No. 34/1991: Foreign direct investment (FDI) laws in Iceland explicitly bar non-EEA entities—such as a Cayman-incorporated SPAC—from owning energy exploitation rights or associated real estate. Consequently, NIAA cannot directly acquire power generation assets; its target pipeline must focus strictly on downstream applications like data centers (via leasehold models) or cold-chain logistics, or utilize highly complex, untried synthetic local-holding joint ventures.
• Severe Redemption Risks and PIPE Dependency: With late-2026 SPAC redemptions averaging over 90%, NIAA’s $125 million trust is highly likely to be depleted at the business combination vote. Given the Central Bank of Iceland’s recent policy rate hike to 8.00% on August 19, 2026, funding the required target size (averaging $111 million in revenues) will require a heavily structured, dilutive PIPE or convertible debt facility rather than relying on trust cash.

• Burman Takeover and the RBI Demerger Block: The Burman family’s hostile takeover of Religare Enterprises (REL) was completed in February 2025, but structural unlocking remains stalled due to the Reserve Bank of India’s (RBI) rejection of the demerger scheme on August 6, 2026. This delays the separation of the financial services and health insurance arms and pushes the target listing of Religare Finvest (RFL) well past the original Q1 FY28 timeline.
• The Rashmi Saluja ESOP Saga and Key-Man Risk: Former Chairperson Rashmi Saluja’s ₹480 crore ESOP grant (representing ~2.5% of Care Health’s capital) has been declared illegal by IRDAI. Following her removal, the new board withdrew Care’s SAT appeal in July 2025, and a Mumbai court granted her bail in May 2026 amid ongoing EOW charges. While key-man risk has subsided, legacy legal cleanup remains a drag.
• Care Health’s Underwriting Pain vs. Peer Performance: Despite strong topline growth with gross premiums crossing ₹10,031 crore in FY26, Care’s profitability fell 92% YoY to ₹12.16 crore as its combined ratio deteriorated to 106.7%. This underperformance is exacerbated by the new 1/n accounting rule and a thin 1.68x solvency margin, lagging behind Star Health’s retail-focused underwriting discipline (98.8% combined ratio).